Overview
- Editors:
-
-
Georges Mathé
-
Institut de Cancérologie et d’Immunogénétique, Hôpital Paul-Brousse, Villejuif, France
-
Robert K. Oldham
-
Cellular and Tumor Immunology Section Department of Health, Education and Welfare, N.I.H., Bethesda, USA
Access this book
Other ways to access
Table of contents (20 papers)
-
-
-
-
-
-
- V. Rodriguez, G. P. Bodey, E. J. Freireich
Pages 24-28
-
- C. Jasmin, F. Bricout, J. M. Huraux, R. Weiner, R. K. Oldham, G. Mathé
Pages 29-33
-
-
- A. Bussel, M. Benbunan, M. Weil, J. Reviron, C. Jacquillat, M. Boiron et al.
Pages 40-47
-
- H.-P. Lohrmann, M. I. Bull, J. A. Decter, R. A. Yankee, R. G. Graw Jr.
Pages 48-55
-
- J. Breard, R. S. Weiner, R. K. Oldham, G. Mathé
Pages 56-60
-
- C. Griscelli, H. Betuel, C. Herzog, J. L. Touraine, J. P. Revillard
Pages 61-73
-
- A. Khan, J. M. Hill, E. Loeb, A. MacLellan, N. O. Hill
Pages 74-80
-
-
- F. Spreafico, M. G. Donelli, A. Vecchi, A. Bossi, S. Garattini
Pages 88-94
-
- I. Bartošek, M. G. Donelli, A. Guaitani
Pages 95-100
-
-
- Th. Lincoln, E. J. Freireich
Pages 103-107
-
- G. P. Canellos, V. T. de Vita, J. C. Arseneau, R. C. Johnson
Pages 108-114
-
- D. Belpomme, P. Carde, R. K. Oldham, G. Mathé, C. Jacquillat, N. Chelloul et al.
Pages 115-123
About this book
G. MATHE and R. K. OLDHAM'~ Institut de Cancerologie et d'Immunogem!tique, Hopital Paul Brousse, Villejuif Since the last war, cancer chemotherapy has been the object of very intensive and expensive research. Nevertheless, its development has been very slow, and its ultimate potential is today somewhat in doubt. In doubt because it does not cure any cancer patients except a) females carrying placental choriocarcinoma, a semi-allogenic tumor, in which case, cure may be in fluenced by immune rejection, and b) children suffering from Burkitt's tumor, where the probable reason for the cure is that all the neoplastic cells are in the cycle, which is a unique condition among all the human tumor varieties. Whether the long term survivors in acute leukemia, lymphomas, certain sarcomas and certain testicular tumors are "cures" will require longer follow-up. The idea that chemotherapy does not cure most cancer patients because all their neoplastic cells are not in cycle has led to the use of drug combinations. Whatever they are, "cocktail combinations" which are made up of drugs given according to any timing, or scientific combinations, based on pharmacodynamics, pharmaco kinetics or cell kinetics data, are more toxic than single drugs, and are all the more toxic as the number of drugs in the combination is increased.
Editors and Affiliations
-
Institut de Cancérologie et d’Immunogénétique, Hôpital Paul-Brousse, Villejuif, France
Georges Mathé
-
Cellular and Tumor Immunology Section Department of Health, Education and Welfare, N.I.H., Bethesda, USA
Robert K. Oldham